BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 19846672)

  • 21. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa.
    Cacciarelli TV; Martinez OM; Gish RG; Villanueva JC; Krams SM
    Hepatology; 1996 Jul; 24(1):6-9. PubMed ID: 8707283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon alfa down-regulates CD81 in patients with chronic hepatitis C.
    Kronenberger B; Rüster B; Elez R; Weber S; Piiper A; Lee JH; Roth WK; Zeuzem S
    Hepatology; 2001 Jun; 33(6):1518-26. PubMed ID: 11391542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein interferon-stimulated gene 15 conjugation delays but does not overcome coronavirus proliferation in a model of fulminant hepatitis.
    Ma XZ; Bartczak A; Zhang J; He W; Shalev I; Smil D; Chen L; Phillips J; Feld JJ; Selzner N; Levy G; McGilvray I
    J Virol; 2014 Jun; 88(11):6195-204. PubMed ID: 24648452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of alpha interferon anti-hepatitis C virus activity by ISG15.
    Chua PK; McCown MF; Rajyaguru S; Kular S; Varma R; Symons J; Chiu SS; Cammack N; Nájera I
    J Gen Virol; 2009 Dec; 90(Pt 12):2929-2939. PubMed ID: 19656964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-mediated ISG15 conjugation restricts dengue virus 2 replication.
    Hishiki T; Han Q; Arimoto K; Shimotohno K; Igarashi T; Vasudevan SG; Suzuki Y; Yamamoto N
    Biochem Biophys Res Commun; 2014 May; 448(1):95-100. PubMed ID: 24769207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ISG15 over-expression inhibits replication of the Japanese encephalitis virus in human medulloblastoma cells.
    Hsiao NW; Chen JW; Yang TC; Orloff GM; Wu YY; Lai CH; Lan YC; Lin CW
    Antiviral Res; 2010 Mar; 85(3):504-11. PubMed ID: 20035788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herc5 attenuates influenza A virus by catalyzing ISGylation of viral NS1 protein.
    Tang Y; Zhong G; Zhu L; Liu X; Shan Y; Feng H; Bu Z; Chen H; Wang C
    J Immunol; 2010 May; 184(10):5777-90. PubMed ID: 20385878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication.
    Sooryanarain H; Rogers AJ; Cao D; Haac MER; Karpe YA; Meng XJ
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling.
    Kim KI; Yan M; Malakhova O; Luo JK; Shen MF; Zou W; de la Torre JC; Zhang DE
    Mol Cell Biol; 2006 Jan; 26(2):472-9. PubMed ID: 16382139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies.
    Larrea E; Aldabe R; Molano E; Fernandez-Rodriguez CM; Ametzazurra A; Civeira MP; Prieto J
    Gut; 2006 Aug; 55(8):1188-96. PubMed ID: 16120756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ubiquitin-like protein modifiers and their potential for antiviral and anti-HCV therapy.
    Chen L; Li S; Li Y; Duan X; Liu B; McGilvray I
    Expert Rev Proteomics; 2013 Jun; 10(3):275-87. PubMed ID: 23777217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of hepatitis C virus replication by IFN-mediated ISGylation of HCV-NS5A.
    Kim MJ; Yoo JY
    J Immunol; 2010 Oct; 185(7):4311-8. PubMed ID: 20810994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of hepatitis E virus infection on interferon production
    Wang M; Huang Y; He M; Peng WJ; Tian DY
    World J Gastroenterol; 2018 May; 24(20):2173-2180. PubMed ID: 29853735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High interferon-stimulated gene ISG-15 expression affects HCV treatment outcome in patients co-infected with HIV and HCV.
    Katsounas A; Hubbard JJ; Wang CH; Zhang X; Dou D; Shivakumar B; Winter S; Schlaak JF; Lempicki RA; Masur H; Polis M; Kottilil S; Osinusi A
    J Med Virol; 2013 Jun; 85(6):959-63. PubMed ID: 23588721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and Herc5-mediated ISGylation of novel target proteins.
    Takeuchi T; Inoue S; Yokosawa H
    Biochem Biophys Res Commun; 2006 Sep; 348(2):473-7. PubMed ID: 16884686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A negative feedback of the HIF-1α pathway via interferon-stimulated gene 15 and ISGylation.
    Yeh YH; Yang YC; Hsieh MY; Yeh YC; Li TK
    Clin Cancer Res; 2013 Nov; 19(21):5927-39. PubMed ID: 24056783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consecutive Inhibition of ISG15 Expression and ISGylation by Cytomegalovirus Regulators.
    Kim YJ; Kim ET; Kim YE; Lee MK; Kwon KM; Kim KI; Stamminger T; Ahn JH
    PLoS Pathog; 2016 Aug; 12(8):e1005850. PubMed ID: 27564865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation.
    Kim KI; Giannakopoulos NV; Virgin HW; Zhang DE
    Mol Cell Biol; 2004 Nov; 24(21):9592-600. PubMed ID: 15485925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ISG15 Arg151 and the ISG15-conjugating enzyme UbE1L are important for innate immune control of Sindbis virus.
    Giannakopoulos NV; Arutyunova E; Lai C; Lenschow DJ; Haas AL; Virgin HW
    J Virol; 2009 Feb; 83(4):1602-10. PubMed ID: 19073728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes.
    Testoni B; Durantel D; Lebossé F; Fresquet J; Helle F; Negro F; Donato MF; Levrero M; Zoulim F
    Gut; 2016 Apr; 65(4):672-82. PubMed ID: 26082258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.